{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:04:16Z","timestamp":1758992656913},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.toxlet.2013.02.021","type":"journal-article","created":{"date-parts":[[2013,3,4]],"date-time":"2013-03-04T22:13:39Z","timestamp":1362435219000},"page":"59-64","source":"Crossref","is-referenced-by-count":20,"title":["Monitoring abacavir bioactivation in humans: Screening for an aldehyde metabolite"],"prefix":"10.1016","volume":"219","author":[{"given":"N\u00e1dia M.","family":"Grilo","sequence":"first","affiliation":[]},{"given":"Alexandra M.M.","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Umbelina","family":"Caixas","sequence":"additional","affiliation":[]},{"given":"Aline T.","family":"Marinho","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Charneira","sequence":"additional","affiliation":[]},{"given":"M.","family":"Concei\u00e7\u00e3o Oliveira","sequence":"additional","affiliation":[]},{"given":"Em\u00edlia C.","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"M.","family":"Matilde Marques","sequence":"additional","affiliation":[]},{"given":"Sofia A.","family":"Pereira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2013.02.021_bib0005","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/eji.201142159","article-title":"Avidity determines T-cell reactivity in abacavir hypersensitivity","volume":"42","author":"Adam","year":"2012","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-010611-134701","article-title":"Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex","volume":"52","author":"Bharadwaj","year":"2012","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0015","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1021\/tx200337b","article-title":"Reactive aldehyde metabolites from the anti-HIV drug abacavir: amino acid adducts as possible factors in abacavir toxicity","volume":"24","author":"Charneira","year":"2011","journal-title":"Chemical Research in Toxicology"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0020","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1476-5381.2012.02079.x","article-title":"N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivo","volume":"167","author":"Charneira","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0025","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11904-010-0047-3","article-title":"Abacavir and cardiovascular risk: reviewing the evidence","volume":"7","author":"Costagliola","year":"2010","journal-title":"Current HIV\/AIDS Reports"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0035","doi-asserted-by":"crossref","first-page":"a3172","DOI":"10.1136\/bmj.a3172","article-title":"HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity","volume":"338","author":"Deeks","year":"2009","journal-title":"British Medical Journal"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0040","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00002030-199208000-00008","article-title":"Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine","volume":"6","author":"De Quay","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0045","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/AAC.41.5.1099","article-title":"Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89","volume":"41","author":"Faletto","year":"1997","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0050","unstructured":"FDA alert, 2011. Abacavir \u2013 Ongoing Safety Review: Possible Increased Risk of Heart Attack. http:\/\/www.drugs.com\/fda\/abacavir-ongoing-safety-review-possible-increased-risk-heart-attack-12914.html (accessed 22.01.13)."},{"key":"10.1016\/j.toxlet.2013.02.021_bib0055","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3390\/ijerph7041285","article-title":"Alcohol and acetaldehyde in public health: from marvel to menace","volume":"7","author":"Guo","year":"2010","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0060","doi-asserted-by":"crossref","first-page":"e8757","DOI":"10.1371\/journal.pone.0008757","article-title":"Alcohol dehydrogenase accentuates ethanol-induced myocardial dysfunction and mitochondrial damage in mice: role of mitochondrial death pathway","volume":"5","author":"Guo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003495-200060020-00015","article-title":"Abacavir: a review of its clinical potential in patients with HIV infection","volume":"60","author":"Hervey","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0070","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","article-title":"Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis","volume":"13","author":"Islam","year":"2012","journal-title":"HIV Medicine"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jaci.2011.09.007","article-title":"Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality","volume":"129","author":"Linneberg","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0085","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00204-004-0619-3","article-title":"Cutaneous metabolism of glycol ethers","volume":"79","author":"Lockley","year":"2005","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0090","doi-asserted-by":"crossref","first-page":"H3673","DOI":"10.1152\/ajpheart.00284.2007","article-title":"Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure","volume":"293","author":"Luo","year":"2007","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"Suppl. 4","key":"10.1016\/j.toxlet.2013.02.021_bib0095","first-page":"18119","article-title":"Abacavir and the altered peptide repertoire model: clinical implications","volume":"15","author":"Mallal","year":"2012","journal-title":"Journal of the International AIDS Society"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0100","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.43.12.2855","article-title":"Pharmacokinetics of [14C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study","volume":"43","author":"McDowell","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10408360902937817","article-title":"HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects","volume":"46","author":"Nolan","year":"2009","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0110","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e328355fe8f","article-title":"Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity","volume":"26","author":"Norcross","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/10408440591002183","article-title":"Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health","volume":"35","author":"O\u2019Brien","year":"2005","journal-title":"Critical Reviews in Toxicology"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0120","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/187152808785748128","article-title":"The role of inflammation and allergy in acute coronary syndromes","volume":"7","author":"Ozben","year":"2008","journal-title":"Inflammation & Allergy \u2013 Drug Targets"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0130","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1158\/1055-9965.EPI-04-0431","article-title":"The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use","volume":"14","author":"Peters","year":"2005","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2332\/allergolint.55.17","article-title":"Pharmacological interaction of drugs with immune receptors: the p\u2013i concept","volume":"55","author":"Pichler","year":"2006","journal-title":"Allergology International"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0300-483X(02)00255-X","article-title":"The danger hypothesis\u2014potential role in idiosyncratic drug reactions","volume":"181\u2013182","author":"Pirmohamed","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/15563659008993494","article-title":"Experimental studies on the acute cardiovascular toxicity of formalin and its antidotal treatment","volume":"28","author":"Strubelt","year":"1990","journal-title":"Journal of Toxicology \u2013 Clinical Toxicology"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0150","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1570-0232(02)00172-1","article-title":"Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications","volume":"778","author":"T\u00f6rnqvist","year":"2002","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.pharmtox.47.120505.105150","article-title":"Idiosyncratic drug reactions: current understanding","volume":"47","author":"Uetrecht","year":"2007","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0009-2797(02)00059-5","article-title":"The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes","volume":"142","author":"Walsh","year":"2002","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.toxlet.2013.02.021_bib0170","doi-asserted-by":"crossref","first-page":"e1000441","DOI":"10.1371\/journal.pcbi.1000441","article-title":"Harvesting candidate genes responsible for serious adverse drug reactions from a chemical\u2013protein interactome","volume":"5","author":"Yang","year":"2009","journal-title":"PLoS Computational Biology"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427413000908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427413000908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T20:47:20Z","timestamp":1715028440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427413000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0378427413000908"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2013.02.021","relation":{},"ISSN":["0378-4274"],"issn-type":[{"type":"print","value":"0378-4274"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}